GS-0272

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-0272, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-0272 in Participants With Rheumatoid Arthritis [Phase 1]